PiRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma

Leukemia

Volumn 29, Issue 1, 2015, Pages 196-206

  Yan, H ^a   Wu, Q L ^a   Sun, C Y ^a   Ai, L S ^a   Deng, J ^a   Zhang, L ^a   Chen, L ^a   Chu, Z B ^a   Tang, B ^a   Wang, K ^a   Wu, X F ^a   Xu, J ^a   Hu, Y ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PIWI INTERACTING RNA; PIWI INTERACTING RNA 823; UNCLASSIFIED DRUG; VASCULOTROPIN; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE ASSAY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; GENETIC EPIGENESIS; GENETICS; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

CARCINOGENESIS; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING;

EID: 84920695432     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.135     Document Type: Article

References (57)

1. Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. Nat Rev Cancer 2012; 12: 335-348.
2. Chng WJ, Glebov O, Bergsagel PL, Kuehl WM. Genetic events in the pathogenesis of multiple myeloma. Best Pract Res Clin Haematol 2007; 20: 571-596.
3. Chim CS, Liang R, Leung MH, Kwong YL. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma. J Clin Pathol 2007; 60: 104-106.
4. Galm O, Wilop S, Reichelt J, Jost E, Gehbauer G, Herman JG et al. DNA methylation changes in multiple myeloma. Leukemia 2004; 18: 1687-1692.
5. Walker BA, Wardell CP, Chiecchio L, Smith EM, Boyd KD, Neri A et al. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. Blood 2011; 117: 553-562.
6. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
7. Heller G, Schmidt WM, Ziegler B, Holzer S, Mullauer L, Bilban M et al. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. Cancer Res 2008; 68: 44-54.
8. Kaiser MF, Johnson DC, Wu P, Walker BA, Brioli A, Mirabella F et al. Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood 2013; 122: 219-226.
9. Amodio N, Leotta M, Bellizzi D, Di Martino MT, D'Aquila P, Lionetti M et al. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget 2012; 3: 1246-1258.
10. Zhou H, Hu H, Lai M. Non-coding RNAs and their epigenetic regulatory mechanisms. Biol Cell 2010; 102: 645-655.
11. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
12. Wong KY, Yim RL, So CC, Jin DY, Liang R, Chim CS. Epigenetic inactivation of the MIR34B/C in multiple myeloma. Blood 2011; 118: 5901-5904.
13. Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010; 18: 367-381.
14. Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG et al. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis 2010; 31: 745-750.
15. Aravin AA, Sachidanandam R, Bourc'his D, Schaefer C, Pezic D, Toth KF et al. A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. Mol Cell 2008; 31: 785-799.
16. Aravin AA, Bourc'his D. Small RNA guides for de novo DNA methylation in mammalian germ cells. Genes Dev 2008; 22: 970-975.
17. Watanabe T, Tomizawa S, Mitsuya K, Totoki Y, Yamamoto Y, Kuramochi-Miyagawa S et al. Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science 2011; 332: 848-852.
18. Grivna ST, Beyret E, Wang Z, Lin H. A novel class of small RNAs in mouse spermatogenic cells. Genes Dev 2006; 20: 1709-1714.
19. Girard A, Sachidanandam R, Hannon GJ, Carmell MA. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature 2006; 442: 199-202.
20. Aravin A, Gaidatzis D, Pfeffer S, Lagos-Quintana M, Landgraf P, Iovino N et al. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 2006; 442: 203-207.
21. Kuramochi-Miyagawa S, Watanabe T, Gotoh K, Totoki Y, Toyoda A, Ikawa M et al. DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev 2008; 22: 908-917.
22. Aravin AA, Sachidanandam R, Girard A, Fejes-Toth K, Hannon GJ. Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 2007; 316: 744-747.
23. Siddiqi S, Terry M, Matushansky I. Hiwi mediated tumorigenesis is associated with DNA hypermethylation. PLoS One 2012; 7: e33711.
24. Siddiqi S, Matushansky I. Piwis and piwi-interacting RNAs in the epigenetics of cancer. J Cell Biochem 2012; 113: 373-380.
25. Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C. Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science 2010; 330: 1824-1827.
26. Cheng J, Guo JM, Xiao BX, Miao Y, Jiang Z, Zhou H et al. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 2011; 412: 1621-1625.
27. Cui L, Lou Y, Zhang X, Zhou H, Deng H, Song H et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. Clin Biochem 2011; 44: 1050-1057.
28. Cheng J, Deng H, Xiao B, Zhou H, Zhou F, Shen Z et al. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett 2012; 315: 12-17.
29. Hu Y, Wang YD, Guo T, Wei WN, Sun CY, Zhang L et al. Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma. Cancer Genet Cytogenet 2007; 178: 1-10.
30. Huang G, Hu H, Xue X, Shen S, Gao E, Guo G et al. Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer. Clin Transl Oncol 2013; 15: 563-568.
31. Law PT, Qin H, Ching AK, Lai KP, Co NN, He M et al. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma. J Hepatol 2013; 58: 1165-1173.
32. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
33. Lamorte S, Ferrero S, Aschero S, Monitillo L, Bussolati B, Omede P et al. Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells. Leukemia 2012; 26: 1081-1090.
34. Chim CS, Kwong YL, Liang R. Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approach. Clin Lymphoma Myeloma 2008; 8: 331-339.
35. Park G, Kang SH, Lee JH, Suh C, Kim M, Park SM et al. Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets. Ann Hematol 2011; 90: 73-79.
36. Vacca A, Ria R, Ribatti D, Semeraro F, Djonov V, Di Raimondo F et al. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angio-genesis and growth in multiple myeloma. Haematologica 2003; 88: 176-185.
37. Ria R, Vacca A, Russo F, Cirulli T, Massaia M, Tosi P et al. A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma. Thromb Haemost 2004; 92: 1438-1445.
38. Zhang H, Ren Y, Xu H, Pang D, Duan C, Liu C. The expression of stem cell protein Piwil2 and piR-932 in breast cancer. Surg Oncol 2013; 22: 217-223.
39. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-3420.
40. Wu P, Agnelli L, Walker BA, Todoerti K, Lionetti M, Johnson DC et al. Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol 2013; 162: 348-359.
41. Chi J, Ballabio E, Chen XH, Kusec R, Taylor S, Hay D et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct 2011; 6: 23.
42. Wang Y, Liu Y, Shen X, Zhang X, Chen X, Yang C et al. The PIWI protein acts as a predictive marker for human gastric cancer. Int J Clin Exp Pathol 2012; 5: 315-325.
43. He W, Wang Z, Wang Q, Fan Q, Shou C, Wang J et al. Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. BMC Cancer 2009; 9: 426.
44. Grochola LF, Greither T, Taubert H, Moller P, Knippschild U, Udelnow A et al. The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br J Cancer 2008; 99: 1083-1088.
45. Lee JH, Schutte D, Wulf G, Fuzesi L, Radzun HJ, Schweyer S et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 2006; 15: 201-211.
46. Lee JH, Jung C, Javadian-Elyaderani P, Schweyer S, Schutte D, Shoukier M et al. Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2. Cancer Res 2010; 70: 4569-4579.
47. Chim CS, Fung TK, Liang R. Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS. Leukemia 2003; 17: 2533-2535.
48. Kramer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD et al. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma. Leukemia 2002; 16: 1844-1851.
49. Chim CS, Liang R, Fung TK, Kwong YL. Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myeloma. Leukemia 2005; 19: 2352-2355.
50. Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F. Bone marrow angio-genesis in patients with active multiple myeloma. Semin Oncol 2001; 28: 543-550.
51. Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy MQ et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000; 6: 3111-3116.
52. Zhu D, Hunter SB, Vertino PM, Van Meir EG. Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. Cancer Res 2011; 71: 5859-5870.
53. Hellebrekers DM, Jair KW, Vire E, Eguchi S, Hoebers NT, Fraga MF et al. Angiostatic activity of DNA methyltransferase inhibitors. Mol Cancer Ther 2006; 5: 467-475.
54. Claudio PP, Stiegler P, Howard CM, Bellan C, Minimo C, Tosi GM et al. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer Res 2001; 61: 462-468.
55. Takeuchi H, Ozawa S, Shih CH, Ando N, Kitagawa Y, Ueda M et al. Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus. Int J Cancer 2004; 109: 483-490.
56. Schulz P, Scholz A, Rexin A, Hauff P, Schirner M, Wiedenmann B et al. Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis. Br J Cancer 2008; 99: 110-117.
57. Gibson SL, Dai CY, Lee HW, DePinho RA, Gee MS, Lee WM et al. Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus. Cancer Res 2003; 63: 742-746.